Insights On Quality Control
-
Innovative Technology For Developing, Scaling Peptide-Based Therapeutics
11/18/2024
Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.
-
Breaking Barriers In Malaria Prevention With A Mobile Cleanroom
6/19/2024
The delivery of this mobile cGMP cleanroom facility to ACT showcases Germfree’s commitment to providing innovative solutions that meet clients' unique needs and contribute to advancing healthcare.
-
Integration Of Container Closure Integrity In Contract Manufacturing
3/28/2025
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
Improved GLP-1 Receptor Agonist Peptide Recovery
6/30/2025
Discover how an innovative technology enhances LC-MS analysis of GLP-1 receptor agonists by minimizing peptide loss and improving assay sensitivity and consistency.
-
Accelerate Biologics Product Release With Seamless Viral Testing
6/23/2025
Explore viral safety testing for biologics, focusing on prevention, detection, and removal strategies, updated regulatory guidance, and common challenges in unprocessed bulk testing.
-
Building Control Strategies: It's Time To Go Digital
1/24/2025
Digital control strategies in pharma enhance product quality, regulatory compliance, and efficiency by leveraging real-time monitoring, automated documentation, and Quality by Design (QbD) frameworks.
-
Don't Skip Preformulation: Your Blueprint For Drug Development Success
9/22/2023
Investing in the right preformulation studies and gathering evidence to inform decisions is critical to identify product dead-ends and failure modes without the pain of hindsight.
-
The Pain Of Change – Could Suppliers Be Part Of The Cure?
10/15/2024
Change is a constant in the pharma industry, but it doesn't have to be painful. Discover how suppliers can help ease the burden of regulatory change management and streamline essential processes.
-
Understanding cGMPs For Phase 1 Investigational Drugs
8/15/2025
Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.
-
Strategic CMC Planning Through A Phase-Appropriate Quality Approach
5/28/2024
A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development stage. Watch to learn how to apply such an approach to chemistry, manufacturing, and controls planning.